Understanding how certain strains of group A streptococcus cause infections without their usual protective capsule.
Impact of regulatory cross-talk on the pathophysiology of emergent acapsular group A streptococcus
This study is looking at how certain types of group A strep bacteria can still cause serious infections even without their usual protective coating, and it aims to help doctors understand these bacteria better so they can find better ways to treat infections in patients.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Tx Md Anderson Can Ctr NIH-funded |
| Lab location | 1 site (Houston, United States) |
| Project ID | NIH-10449272 on NIH RePORTER |
What this research studies
This research investigates the mechanisms by which acapsular strains of group A streptococcus (GAS) lead to serious infections. It focuses on the genetic differences in these strains, particularly in the promoters of key genes that regulate virulence. By using comparative genomics, the study aims to uncover how these strains can still infect humans despite lacking the protective capsule typically associated with GAS. Patients may benefit from insights gained into the pathogenicity of these strains, potentially leading to improved treatment strategies.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals who have experienced infections caused by group A streptococcus, particularly those with acapsular strains.
Not a fit: Patients with infections caused by encapsulated strains of group A streptococcus may not benefit directly from this research.
Why it matters
Potential benefit: If successful, this research could lead to better understanding and treatment options for infections caused by acapsular group A streptococcus.
How similar studies have performed: While the specific focus on acapsular GAS is relatively novel, previous research has successfully explored the pathogenic mechanisms of various bacterial infections.
Where this research is happening
Houston, United States
- University of Tx Md Anderson Can Ctr — Houston, United States (Active)
Researchers
- Principal investigator: Shelburne, Samuel a — University of Tx Md Anderson Can Ctr
- Study coordinator: Shelburne, Samuel a
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.